MFDS
- Marketing authorisation holder: GENZYME CORP
- Status: likely_approved
🇰🇷 Wayrilz in South Korea
Wayrilz (RILZABRUTINIB) regulatory status in South Korea.
Marketing authorisation
Wayrilz in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in South Korea
Frequently asked questions
Is Wayrilz approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Wayrilz in South Korea?
GENZYME CORP holds the South Korean marketing authorisation.